韩国国家肺癌CT筛查项目中检出的间质性肺异常的临床结局
该全国性回顾性研究分析2019年8月至2020年12月韩国国家肺癌筛查项目的基线CT结构化报告,在125 600人中ILA患病率为2.65%,且与年龄增长相关。ILA组肺癌、特发性肺纤维化及全因死亡率均显著高于无ILA组,多变量分析显示ILA与肺癌、IPF和死亡风险升高相关。
要点
- 肺癌筛查CT结构化报告可识别ILA,患病率2.65%,随年龄增长而升高。
- ILA组肺癌发生率2009 vs 412/10万人年,全因死亡率2334 vs 712/10万人年。
- ILA组IPF发生率为1344 vs 18/10万人年,调整后风险为63.4倍。
核心结论
- ILA的存在与肺癌、特发性肺纤维化及死亡风险升高相关。
研究设计与样本
- 全国性、基于人群的回顾性研究,分析2019年8月至2020年12月韩国国家肺癌筛查项目的基线筛查,共125 600人(平均年龄62岁±5.3,123 331名男性),由项目放射科医生视觉评估CT结构化报告识别ILA。
诊断标准与关键数值
- ILA患病率为2.65%(3324/125 600),与年龄增长强相关(P < .001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Limited evidence exists on the prevalence and outcomes of interstitial lung abnormalities (ILAs) in lung cancer screening populations, particularly Asian populations. Purpose To investigate the prevalence of ILAs and the association of ILAs with lung cancer, idiopathic pulmonary fibrosis (IPF), and mortality outcomes in an Asian population. Materials and Methods In this nationwide, population-based retrospective study, baseline screenings from the Korean National Lung Cancer Screening Program performed between August 2019 and December 2020 were analyzed. ILAs were identified from CT structured reports based on program radiologists' visual assessment, and ILA prevalence was analyzed across age groups. Incidence rate ratios were calculated for lung cancer incidence, IPF, and all-cause mortality comparing individuals with ILAs versus individuals without ILAs, and multivariable Cox regression analyses were performed to examine associations between ILAs and these outcomes. Results Among 125 600 individuals (mean age, 62 years ± 5.3 [SD]; 123 331 men), ILA prevalence was 2.65% (3324 of 125 600) and was strongly associated with older age (P < .001). The lung cancer incidence rate was higher in the ILA group (2009 vs 412 per 100 000 person-years, P < .001; incidence rate ratio, 4.88), as was the all-cause mortality rate (2334 vs 712 per 100 000 person-years, P < .001; incidence rate ratio, 3.28). During a median follow-up of 2.9 years, IPF was diagnosed in 3.55% (118 of 3324) of individuals with ILAs (incidence rate, 1344 per 100 000 person-years in group with ILAs vs 18 per 100 000 person-years in group without ILAs, P < .001; incidence rate ratio, 73.24). In multivariable analyses, individuals with ILAs had a threefold higher risk of lung cancer (adjusted hazard ratio, 3.18 [95% CI: 2.71, 3.73]; P < .001) and twofold higher all-cause mortality (adjusted hazard ratio, 2.37 [95% CI: 2.09, 2.69]; P < .001). Individuals with ILAs showed a markedly higher risk of IPF diagnosis, with more than 60-fold higher risk (adjusted hazard ratio, 63.4 [95% CI: 45.9, 87.7]; P < .001). Conclusion The presence of ILAs was associated with higher risks of lung cancer, IPF, and mortality. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Baruah and Kabakus in this issue.
引用
- Kim H, Jo E, Kim J, et al. Clinical Outcomes of Interstitial Lung Abnormalities Detected in the Korean National Lung Cancer CT Screening Program. Radiology. 2025. PMID: 40423536. doi:10.1148/radiol.243651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。